Skip to content

Red flags and safety concerns

TL;DR — A prior migraine diagnosis never explains a new thunderclap, persistent neurological deficit, papilledema, fever/meningism, impaired consciousness, pregnancy/postpartum change, cancer/immunosuppression context or major pattern change. SNNOOP10 organizes secondary-headache signals, but individual red flags have limited specificity and the tool is a prompt for targeted evaluation rather than a validated universal rule-out test (Do 2019, PMID 30587518; Chu 2024, PMID 38658053). Thunderclap headache requires urgent assessment for subarachnoid hemorrhage and other vascular causes including RCVS, venous thrombosis and dissection; a normal early test is interpreted by timing, technique and residual probability. Migraine-consistent recurrent headache with a normal examination and no atypical feature does not require routine imaging (Evans 2020, PMID 31891197). Medication safety includes class contraindications, cumulative dose, sedation/driving, pregnancy, dependence/withdrawal and MOH—not only rare serious adverse events.

Red flags are probability modifiers

Signal Secondary causes raised Why not diagnostic alone
Systemic symptoms/fever Infection, vasculitis Viral illness can trigger primary headache
Neoplasm/immunosuppression Mass, infection Many patients still have primary headache
Neurological deficit/confusion Stroke, seizure, mass, encephalitis Typical aura is reversible focal dysfunction
Sudden/thunderclap onset SAH, RCVS, dissection, CVT Some primary thunderclap exists only after exclusion
New onset age >50 GCA, mass, vascular disease Migraine can persist or rarely start late
Pattern/progression change Mass, pressure disorder, overuse Migraine frequency naturally fluctuates
Positional/Valsalva CSF pressure disorder, Chiari, mass Non-specific neck/musculoskeletal influence
Papilledema Raised intracranial pressure Requires eye/pressure evaluation, not migraine treatment
Pregnancy/postpartum Preeclampsia, CVT, RCVS, dissection Primary migraine remains common
Painful eye/autonomic signs Acute glaucoma, pituitary/cavernous pathology, TAC Migraine can produce cranial autonomic symptoms

The SNNOOP10 review added progressive/atypical presentation, precipitated by exertion, painful eye with autonomic features, post-traumatic onset, immune pathology and medication-related triggers to older SNOOP mnemonics (Do 2019, PMID 30587518).

In a multinational emergency cohort, common red flags were frequent even without serious secondary headache, confirming low specificity and the danger of automatic imaging for any single item (Chu 2024, PMID 38658053).

Immediate emergency patterns

Pattern Immediate concern
Maximal intensity within seconds/minute SAH, RCVS, dissection, CVT
New persistent weakness, aphasia, field loss or ataxia Ischemic/hemorrhagic stroke
Fever + meningism/altered state Meningitis/encephalitis
Seizure + new headache Hemorrhage, CVT, mass, infection, PRES
Severe headache + high BP/pregnancy visual symptoms Preeclampsia/eclampsia/PRES
Painful red eye + blurred vision/halos/vomiting Acute angle closure
Sudden headache + ophthalmoplegia/visual loss/hypotension Pituitary apoplexy

This page is research synthesis, not an emergency triage substitute.

Thunderclap headache

Thunderclap describes time to peak, not severity alone. Subarachnoid hemorrhage is the time-critical prototype, but RCVS, CVT, dissection, pituitary apoplexy, PRES and spontaneous intracranial hypotension can also present abruptly.

The Ottawa SAH rule was developed for alert adults with new severe nontraumatic headache reaching maximum within one hour. Criteria include age ≥40, neck pain/stiffness, witnessed loss of consciousness, exertional onset, thunderclap and limited neck flexion. External validation shows high sensitivity at the cost of very low specificity; it decides who needs investigation, not who has SAH (Bellolio 2015, PMID 25511365; Foley 2021, PMID 33762366).

Test step Strength Boundary
Noncontrast head CT Rapid detection of blood, mass effect Sensitivity falls with time and varies by scanner/reader/anemia
Lumbar puncture Xanthochromia/RBC and alternative infection/pressure data Traumatic tap, timing and complications
CTA/MRA Aneurysm/vasculopathy/dissection Incidental aneurysm and radiation/contrast by modality
Repeat vascular imaging Demonstrates evolution/reversibility in RCVS Initial angiography may be normal early

Clinical decision rules apply only to their enrolled population; a patient with focal deficit, papilledema or trauma exits the simple rule pathway.

Reversible cerebral vasoconstriction syndrome

RCVS typically causes recurrent thunderclap headaches over days, sometimes with seizures, focal deficits, convexity SAH, ischemic stroke or PRES. Vasoactive drugs, postpartum state and other triggers are common but not required. The classic “string of beads” can be absent early or mimicked; case-based review emphasizes serial clinical/imaging reasoning (Kim 2025, PMID 40289076).

Calling recurrent thunderclap “migraine” because pain recurs is a dangerous category error.

Cerebral venous thrombosis

CVT accounts for roughly 0.5–3% of strokes and disproportionately affects younger people, women of reproductive age and prothrombotic states. Headache may be isolated or accompany seizure, papilledema, focal deficit or hemorrhage (Saposnik 2024, PMID 38284265).

MRI/MRV or CT/CTV establishes diagnosis; noncontrast CT can be normal. Reviews report headache as the most common presentation and hemorrhage on imaging in about 40% in some cohorts; contemporary review also emphasizes vague, variable presentation and the need for venous imaging when suspicion persists (Zuurbier 2017, PMID 27628005; Aamodt 2022, PMID 35170006). Pregnancy/postpartum, estrogen exposure, cancer, infection and thrombophilia modify suspicion.

Arterial dissection

Cervical artery dissection can present with new unilateral head/neck pain, partial Horner syndrome, pulsatile tinnitus, cranial neuropathy or later ischemia. It is a major stroke cause in young adults; apparently benign headache/neck pain can precede deficits (Clark 2022, PMID 35506728; Debette 2009, PMID 19539238).

Recent minor neck trauma may occur but is not required. Intracranial dissection is less common than cervical dissection in many Western adult series and can present with headache, ischemia, subarachnoid hemorrhage or mass effect (Debette 2015, PMID 25987283). A history of migraine is reported as an association, not a reason to downgrade new neck/head pain.

Giant cell arteritis

GCA occurs almost exclusively after age 50 and can cause irreversible visual loss, stroke and aortitis. New headache, scalp tenderness, jaw/tongue claudication, visual symptoms, constitutional symptoms and polymyalgia features raise suspicion (Buttgereit 2016, PMID 27299619).

No single historical feature or ESR value rules it in/out; diagnostic-accuracy review shows likelihood shifts are strongest when features combine (Smetana 2002, PMID 11754714). Urgent treatment/testing pathways are required when visual ischemia is possible.

Raised intracranial pressure and papilledema

Papilledema is optic-disc swelling from raised intracranial pressure and demands etiological evaluation. Headache can look migraine-like, so phenotype cannot exclude idiopathic intracranial hypertension or a mass/CVT. Pulsatile tinnitus, transient visual obscurations, diplopia and progressive visual loss support pressure disease.

Neuroimaging and venous assessment precede lumbar puncture in appropriate cases; pressure measurement technique and eye examination matter. Treating pain alone risks preventable visual loss.

Pituitary apoplexy and ocular emergencies

Pituitary apoplexy is acute hemorrhage/infarction in a pituitary lesion, classically sudden severe headache with nausea, visual loss/field defect, ophthalmoplegia, altered consciousness or adrenal insufficiency. Corticotropic failure can cause hypotension and is life-threatening (Iglesias 2024, PMID 38731037; Briet 2015, PMID 26414232).

Acute angle closure causes painful red eye, reduced vision/halos, headache, nausea/vomiting and high intraocular pressure; it is an ophthalmic emergency (Flores-Sánchez 2019, PMID 31822188). Eye pain and autonomic symptoms should not be assumed migraine/cluster without ocular examination when the phenotype is new.

Pregnancy and postpartum

Pregnancy-specific red flags include elevated blood pressure, no prior headache history, prolonged/change from usual migraine, abnormal examination and systemic symptoms (Robbins 2018, PMID 30074551). Secondary causes include preeclampsia/eclampsia, PRES, CVT, dissection, RCVS, pituitary apoplexy and post-dural-puncture headache (Negro 2017, PMID 29052046).

Postpartum headache is common and usually primary/procedural, but timing after neuraxial anesthesia does not exclude CVT or other vascular disease. Reviews emphasize the breadth of hormonal, procedural and vascular causes, while a prospective 900-woman study demonstrates multiple primary and symptomatic etiologies during the first month (Klein 2010, PMID 20833030; Anzola 2017, PMID 29073663).

Postpartum clue Concern
Orthostatic after dural puncture Low-CSF-pressure headache, but reassess atypical course
Thunderclap/recurrent thunderclap RCVS/SAH/dissection
Hypertension + visual/seizure Preeclampsia/eclampsia/PRES
Progressive headache + seizure/papilledema CVT
Ophthalmoplegia/hypotension Pituitary apoplexy

When routine imaging is low value

For stable migraine-consistent attacks, normal neurological examination and no atypical feature/red flag, AHS systematic review found no need for routine neuroimaging. A primary-care diagnostic review likewise places detailed history and examination before targeted testing (Viera 2022, PMID 36126007). Imaging may be considered with prolonged/persistent aura, changed pattern, first/worst event, brainstem/motor features, side-locked or post-traumatic headache, but several indications are consensus-based (Evans 2020, PMID 31891197).

An emergency-department cohort found ICHD-3 criteria and red/green features useful for classification, but a single-center diagnostic study does not make any checklist a universal rule-out instrument (Munoz-Ceron 2019, PMID 30615622).

Imaging can uncover incidental findings that trigger anxiety and further procedures. “No imaging” is appropriate only after adequate history/examination, not as a shortcut.

Medication safety matrix

Class High-priority concern Control
NSAIDs GI bleeding, renal injury, BP/CV risk, pregnancy timing Comorbidity and cumulative-day review
Acetaminophen Duplicate products/hepatotoxic dose Total daily/weekly dose accounting
Triptans Coronary/cerebrovascular contraindications; overuse Vascular history and day limits
Ergot/DHE Vasoconstriction, interactions, pregnancy Avoid contraindicated combinations/exposure
Lasmiditan Dizziness/sedation/driving impairment Post-dose activity restriction
Gepants CYP/transporter interactions; hepatic/renal restrictions Drug-specific reconciliation
Opioid/barbiturate Sedation, dependence, withdrawal and MOH Avoid routine use; supervised taper when dependent
Topiramate Cognitive/ocular/renal and reproductive risk Titration and pregnancy-prevention counseling
Valproate Major fetal/neurodevelopmental and metabolic risk Strong reproductive restrictions
CGRP therapies Constipation/BP/injection reactions; sparse pregnancy data Monitoring and exposure registry

Triptan safety reviews show serious cardiovascular events are rare in appropriately selected users, but trials excluded established high-risk disease; contraindications remain evidence-boundary decisions (Dodick 2004, PMID 15149490). Acute-drug review emphasizes class-specific adverse effects and overuse (Tajti 2015, PMID 25773005).

Medication overuse and withdrawal

MOH requires class-specific overuse for >3 months plus ≥15 headache days/month and is treatable (Ashina 2023, PMID 36732518). Safety concerns are sharper with opioids/barbiturates/benzodiazepine-containing combinations because abrupt withdrawal may be hazardous. A migraine plan should state day limits and an escalation path before the limit is crossed.

Re-evaluation triggers in established migraine

  • first thunderclap or first persistent focal deficit;
  • new headache after age 50;
  • steadily progressive frequency/severity despite treatment;
  • new exertional, cough, sexual or positional headache;
  • papilledema, visual loss or red painful eye;
  • seizure, confusion, fever, weight loss or cancer/immunosuppression;
  • pregnancy/postpartum change;
  • new unilateral neck pain/Horner syndrome;
  • new pattern after trauma or anticoagulation;
  • apparent medication failure accompanied by escalating acute days.

Open questions

  • Which combinations of red and green flags safely reduce imaging while preserving sensitivity? (Chu 2024, PMID 38658053)
  • Can validated pregnancy/postpartum rules distinguish primary headache from CVT/RCVS/preeclampsia? (Robbins 2018, PMID 30074551)
  • How should early normal vascular imaging be handled in recurrent thunderclap suspected RCVS? (Kim 2025, PMID 40289076)
  • What is comparative vascular safety of newer non-vasoconstrictive agents in truly high-risk populations? (Tajti 2015, PMID 25773005)
  • Can refill and diary surveillance prevent MOH without undertreating attacks? (Ashina 2023, PMID 36732518)

References

  1. Do TP, et al. Red and orange flags for secondary headaches: SNNOOP10. Neurology. 2019. PMID 30587518
  2. Chu KH, et al. Predictive performance of common red flags in emergency headache. Emerg Med J. 2024. PMID 38658053
  3. Viera AJ, Antono B. Acute headache in adults: diagnostic approach. Am Fam Physician. 2022. PMID 36126007
  4. Munoz-Ceron J, et al. Headache in the emergency room: red and green flags. PLoS One. 2019. PMID 30615622
  5. Evans RW, et al. Neuroimaging for migraine: AHS guideline. Headache. 2020. PMID 31891197
  6. Bellolio MF, et al. External validation of the Ottawa SAH rule. Am J Emerg Med. 2015. PMID 25511365
  7. Foley RW, et al. External validation of SAH rules in a UK cohort. Clin Med. 2021. PMID 33762366
  8. Kim YJ, et al. Diagnostic pitfalls in reversible cerebral vasoconstriction syndrome. J Headache Pain. 2025. PMID 40289076
  9. Saposnik G, et al. Diagnosis and management of cerebral venous thrombosis: AHA statement. Stroke. 2024. PMID 38284265
  10. Aamodt AH, et al. Cerebral venous thrombosis. Semin Thromb Hemost. 2022. PMID 35170006
  11. Zuurbier SM, et al. Cerebral venous thrombosis. Adv Exp Med Biol. 2017. PMID 27628005
  12. Clark M, et al. Review of carotid and vertebral artery dissection. Br J Hosp Med. 2022. PMID 35506728
  13. Debette S, Leys D. Cervical-artery dissections. Lancet Neurol. 2009. PMID 19539238
  14. Debette S, et al. Intracranial artery dissection. Lancet Neurol. 2015. PMID 25987283
  15. Buttgereit F, et al. Polymyalgia rheumatica and giant cell arteritis: systematic review. JAMA. 2016. PMID 27299619
  16. Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA. 2002. PMID 11754714
  17. Iglesias P. Pituitary apoplexy: updated review. J Clin Med. 2024. PMID 38731037
  18. Briet C, et al. Pituitary apoplexy. Endocr Rev. 2015. PMID 26414232
  19. Flores-Sánchez BC, et al. Acute angle closure glaucoma. Br J Hosp Med. 2019. PMID 31822188
  20. Robbins MS. Headache in pregnancy. Continuum. 2018. PMID 30074551
  21. Negro A, et al. Headache and pregnancy: systematic review. J Headache Pain. 2017. PMID 29052046
  22. Anzola GP, et al. Postpartum headache: prospective study. J Oral Facial Pain Headache. 2017. PMID 29073663
  23. Klein AM, Loder E. Postpartum headache. Int J Obstet Anesth. 2010. PMID 20833030
  24. Ashina S, et al. Medication overuse headache. Nat Rev Dis Primers. 2023. PMID 36732518
  25. Tajti J, et al. Drug safety in acute migraine treatment. Expert Opin Drug Saf. 2015. PMID 25773005
  26. Dodick DW, et al. Cardiovascular tolerability and safety of triptans. Headache. 2004. PMID 15149490